QA: Enfusion Inc in us_software/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001868912_2024_Enfusion_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning No stock price available subcommand.plot {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001868912')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001868912, Enfusion Inc

  xvar xval
0 LiabilitiesCurrent 20,309,000
1 LongTermDebt 11,181,000
2 remainder_Liabilities 0
3 IntangibleAssets 14,304,000
4 AssetsNoncurrent 6,502,000
5 AssetsCurrent 69,852,000
6 PropertyPlantAndEquipmentNet 18,314,000
7 remainder_Assets 0
8 SellingAndMarketingExpense 20,418,000
9 GeneralAndAdministrativeExpense 64,635,000
10 ResearchAndDevelopmentExpense 0
11 remainder_Expenses 79,765,000
12 remainder_Revenues 174,535,000
13 remainder_NetIncome -464,000
14 remainder_ComprehensiveNetIncome -3,130,000
  yvar yval
0 Liabilities 31,490,000
1 Assets 108,972,000
2 Expenses 164,818,000
3 Revenues 174,535,000
4 StockholdersEquity 77,482,000
5 NetIncome 9,253,000
6 ComprehensiveNetIncome 6,123,000
7 BaseVar 241,704,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.73
9 EconomicCapitalRatio 5.03

Edgar->Model Mapping

Feature Distribution

Change over Time